Latest ARCH VENTURE CORP Stock Portfolio
ARCH VENTURE CORP Performance:
2024 Q3: 4.67%YTD: -4.34%2023: -8.31%
Performance for 2024 Q3 is 4.67%, and YTD is -4.34%, and 2023 is -8.31%.
About ARCH VENTURE CORP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $260.6 Millions as of 30 Sep, 2024.
The top stock holdings of ARCH Venture Management, LLC are BEAM, , ERAS. The fund has invested 45.5% of it's portfolio in BEAM THERAPEUTICS INC. and 29.3% of portfolio in RAPPORT THERAPEUTICS, INC.
They significantly reduced their stock positions in BEAM THERAPEUTICS INC. (BEAM).
The top stock holdings of ARCH Venture Management, LLC are BEAM, , ERAS. The fund has invested 45.5% of it's portfolio in BEAM THERAPEUTICS INC. and 29.3% of portfolio in RAPPORT THERAPEUTICS, INC.
They significantly reduced their stock positions in BEAM THERAPEUTICS INC. (BEAM).
ARCH VENTURE CORP Annual Return Estimates Vs S&P 500
Our best estimate is that ARCH Venture Management, LLC made a return of 4.67% in the last quarter. In trailing 12 months, it's portfolio return was 6.24%.
New Buys
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| beam therapeutics inc. | -11.18 |
ARCH VENTURE CORP reduced stake in above stock
Sold off
Sector Distribution
ARCH Venture Management, LLC has about 65.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 65.2 |
| Others | 34.8 |
Market Cap. Distribution
ARCH Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 45.5 |
| UNALLOCATED | 34.8 |
| SMALL-CAP | 15.3 |
| MICRO-CAP | 3 |
| NANO-CAP | 1.3 |
Stocks belong to which Index?
About 60.8% of the stocks held by ARCH Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 60.8 |
| Others | 39.2 |
ARCH VENTURE CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ARCH VENTURE CORP
ARCH Venture Management, LLC has 9 stocks in it's portfolio. VERV proved to be the most loss making stock for the portfolio. BEAM was the most profitable stock for ARCH Venture Management, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| BEAM | beam therapeutics inc. | 45.46 | 4,834,650 | 118,449,000 | reduced | -11.18 | ||
| ERAS | erasca, inc. | 11.58 | 11,055,600 | 30,181,700 | unchanged | 0.00 | ||
| GOSS | gossamer bio, inc. | 3.05 | 8,055,920 | 7,946,360 | unchanged | 0.00 | ||
| OMIC | singular genomics systems, inc. | 0.76 | 126,630 | 1,984,290 | unchanged | 0.00 | ||
| PBAX | cero therapeutics holdings, inc. | 0.05 | 1,444,300 | 134,753 | unchanged | 0.00 | ||
| UBX | unity biotechnology, inc. | 0.57 | 1,004,820 | 1,477,080 | unchanged | 0.00 | ||
| VERV | verve therapeutics, inc. | 3.73 | 2,008,810 | 9,722,640 | unchanged | 0.00 | ||
| rapport therapeutics, inc. | 29.31 | 3,728,740 | 76,364,600 | unchanged | 0.00 | |||
| q32 bio inc. | 5.49 | 320,482 | 14,299,900 | unchanged | 0.00 | |||